	US 12,121,570 B2
	Treatment of stress disorders using acetylcholine release inhibiting neurotoxic proteins to reduce stress levels
Babak Azizzadeh, Beverly Hills, CA (US)
Filed by Babak Azizzadeh, Beverly Hills, CA (US)
Filed on Sep. 11, 2023, as Appl. No. 18/464,583.
Application 18/464,583 is a continuation of application No. 16/736,285, filed on Jan. 7, 2020, granted, now 11,752,201.
Claims priority of provisional application 62/789,126, filed on Jan. 7, 2019.
Prior Publication US 2023/0414729 A1, Dec. 28, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61P 25/22 (2006.01)

CPC A61K 38/4893 (2013.01) [A61K 9/0019 (2013.01); A61P 25/22 (2018.01)]

17 Claims

1. A method of treating a stress disorder, the method comprising:

administering an effective amount of an acetylcholine release inhibiting neurotoxin to an occipitofrontalis of a patient in need thereof.